It's funny how DOC's ONCS which has MERK's keytruda plus electric currents as a medical Pipeline has a higher stock price than ADXS, which is in a phase 3 immuno-oncology trail with FDA's SPA, Fast Track and Orphan Drug designations (whose Phase 2 by the way made new Guinness World Record of 12 Month survival)